Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$128M |
| 2 |
FedEx
FDX
|
+$120M |
| 3 |
Peloton Interactive
PTON
|
+$97.8M |
| 4 |
Newmont
NEM
|
+$78.9M |
| 5 |
Infosys
INFY
|
+$78.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$291M |
| 3 |
Apple
AAPL
|
+$261M |
| 4 |
Microsoft
MSFT
|
+$240M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.85% |
| 2 | Healthcare | 15.63% |
| 3 | Consumer Discretionary | 14.74% |
| 4 | Consumer Staples | 10.36% |
| 5 | Industrials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
MillerKnoll
MLKN
$1.57B
| $22M | 0.04% |
655,377
-626,362
| -49% | -$21.8M |
|
427
Berkshire Hathaway Class A
BRK.A
$1.06T
| $21.9M | 0.04% |
63
| – | – |
|
428
KB Home
KBH
$3.39B
| $21.8M | 0.04% |
651,343
-520,094
| -44% | -$18.7M |
|
429
Western Union
WU
$2.28B
| $21.8M | 0.04% |
1,006,318
-697,695
| -41% | -$15.1M |
|
430
H&R Block
HRB
$6.62B
| $21.8M | 0.04% |
1,392,782
-1,755,488
| -56% | -$30.3M |
|
431
Virtu Financial
VIRT
$6B
| $21.7M | 0.04% |
875,115
+490,023
| +127% | +$11.4M |
|
432
Flowers Foods
FLO
$1.47B
| $21.7M | 0.04% |
964,159
+44,579
| +5% | +$1.04M |
|
433
Worthington Enterprises
WOR
$2.78B
| $21.7M | 0.04% |
685,905
+579,954
| +547% | +$18.1M |
|
434
Broadridge
BR
$20.8B
| $21.6M | 0.04% |
142,728
+6,729
| +5% | +$976K |
|
435
Teledyne Technologies
TDY
$29.5B
| $21.6M | 0.04% |
55,300
-15,057
| -21% | -$5.4M |
|
436
Parker-Hannifin
PH
$126B
| $21.5M | 0.04% |
79,980
-27,041
| -25% | -$6.7M |
|
437
Lear
LEA
$8.56B
| $21.3M | 0.04% |
133,964
+17,799
| +15% | +$2.5M |
|
438
Credicorp
BAP
$30.1B
| $21.2M | 0.04% |
129,436
-1,343
| -1% | -$186K |
|
439
Carrier Global
CARR
$49.8B
| $21.2M | 0.04% |
569,930
-116,348
| -17% | -$4.21M |
|
|
HZNP
440
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $21.1M | 0.04% |
294,254
-99,592
| -25% | -$7.4M |
|
441
ZTO Express
ZTO
$16.2B
| $21.1M | 0.04% |
724,275
-9,194
| -1% | -$270K |
|
442
EPAM Systems
EPAM
$5.69B
| $21.1M | 0.04% |
59,044
+1,113
| +2% | +$371K |
|
443
Brunswick
BC
$5.24B
| $21M | 0.04% |
275,868
-185,616
| -40% | -$13.1M |
|
|
DOCU
444
DocuSign
DOCU
$11.8B
| $21M | 0.04% |
94,599
-13,547
| -13% | -$3.04M |
|
|
FITB
445
Fifth Third Bancorp
FITB
$49.7B
| $20.9M | 0.04% |
771,369
+297,879
| +63% | +$7.52M |
|
446
MGM Resorts International
MGM
$11B
| $20.9M | 0.04% |
674,189
+75,494
| +13% | +$1.94M |
|
447
New York Times
NYT
$10.6B
| $20.8M | 0.04% |
402,328
+289,105
| +255% | +$12.9M |
|
448
Tyler Technologies
TYL
$14.4B
| $20.8M | 0.04% |
48,370
+15,931
| +49% | +$6.57M |
|
449
Generac Holdings
GNRC
$12.2B
| $20.8M | 0.04% |
92,061
+473
| +0.5% | +$102K |
|
450
Dana Inc
DAN
$3.41B
| $20.7M | 0.04% |
1,068,894
-1,219,946
| -53% | -$20.4M |
|
Similar funds
Cliff Asness's Q4 2020 Portfolio in Review
As of Q4 2020, Cliff Asness held 2,327 positions worth $56.4B, down 4.7% from $59.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cliff Asness withdrew a net $9.06B in Q4 2020, closing 151 positions and reducing 1,279 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $291M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Cliff Asness opened a new position in Peloton Interactive worth $122M.
- Cliff Asness's largest Q4 2020 buy was Peloton Interactive: 803,242 shares worth $122M.
- Cliff Asness added most to Zoom in Q4 2020, an estimated $128M increase.
- Cliff Asness's biggest Q4 2020 reduction was Biogen, cutting an estimated $309M.
- Cliff Asness fully exited iShares Core S&P 500 ETF in Q4 2020, selling an estimated $291M.
- Cliff Asness's ten largest holdings make up 19% of its $56.4B portfolio in Q4 2020.
- Cliff Asness opened 157 new positions and closed 151 in Q4 2020.
- Cliff Asness's portfolio value fell 4.7% quarter-over-quarter to $56.4B.
Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.